These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35817084)

  • 1. Bleeding Propensity in Waldenström Macroglobulinemia: Potential Causes and Evaluation.
    Brysland SA; Maqbool MG; Talaulikar D; Gardiner EE
    Thromb Haemost; 2022 Nov; 122(11):1843-1857. PubMed ID: 35817084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Canadian Perspective on the Treatment of Waldenström Macroglobulinemia.
    Kaedbey R; Forward N; Sehn LH; Shafey M; Doucette S; Chen CI
    Curr Oncol; 2022 Sep; 29(10):7122-7139. PubMed ID: 36290837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Waldenström Macroglobulinemia in Limited-Resource Settings.
    Riva E; Tietsche de Moraes Hungría V; Chiattone C; Martínez-Cordero H
    Hematol Oncol Clin North Am; 2023 Aug; 37(4):801-807. PubMed ID: 37258356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies.
    Boutilier AJ; Huang L; Elsawa SF
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: A rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and MECOM mutations.
    Wang L; Tang J; Feng J; Huang Y; Cheng Y; Xu H; Miao Y
    Front Immunol; 2022; 13():1001482. PubMed ID: 36325357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider.
    Butelet A; Poulain S; Jeanpierre E; Srour M; Nudel M; Chauvet P; Bauters A; Susen S; Dupont A; de Charette M
    Leuk Lymphoma; 2022 Dec; 63(13):3100-3104. PubMed ID: 36528585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia.
    Chohan KL; Kapoor P
    Curr Hematol Malig Rep; 2024 Aug; 19(4):163-174. PubMed ID: 38970645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonally related transformation from Waldenström macroglobulinemia to diffuse large B-cell lymphoma with central nervous system involvement at diagnosis: a case report and literature review.
    Chen H; Zhao D; Wang Z; Zhang W; Wang W
    Clin Exp Med; 2023 Dec; 23(8):5473-5476. PubMed ID: 37921873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenario.
    Danesin N; Scapinello G; Del Prete D; Naso E; Berno T; Visentin A; Bonaldi L; Martines A; Bertorelle R; Vianello F; Gurrieri C; Zambello R; Castellani C; Fedrigo M; Rizzo S; Angelini A; Trentin L; Piazza F
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2062. PubMed ID: 38662353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waldenstrom Macroglobulinemia: Clinical Presentation, Diagnosis, and Management in an Elderly Male.
    Shahab S; Semerdzhiev DI; Reeves J; Daniel A; Martin DE; Sukpraprut-Braaten S
    Cureus; 2023 Aug; 15(8):e44127. PubMed ID: 37750145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia.
    Sun H; Fang T; Wang T; Yu Z; Gong L; Wei X; Wang H; He Y; Liu L; Yan Y; Sui W; Xu Y; Yi S; Qiu L; Hao M
    J Transl Med; 2022 Dec; 20(1):576. PubMed ID: 36494694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperviscosity Syndrome Induced Bilateral Visual and Auditory Impairment in Therapy Resistant Waldenström Macroglobulinemia with MYD88 and CXCR4 Mutations.
    Plante MM; Kimbrough EO; Agarwal AK; Jiang L; Bourgeois K; Stamper GC; Stewart MW; Tun HW
    J Blood Med; 2023; 14():639-648. PubMed ID: 38116327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicoradiopathological correlation of symptomatic focal bone marrow lesions in Waldenström Macroglobulinaemia.
    Arulogun SO; Abbasi MA; Pomplun S; O'Neill AT; Wan S; Wechalekar A; D'Sa SP
    Leuk Lymphoma; 2022 Jun; 63(6):1496-1499. PubMed ID: 35067139
    [No Abstract]   [Full Text] [Related]  

  • 14. Chylothorax as an Initial Manifestation of Waldenström macroglobulinemia.
    Rodriguez Botero N; Zerrate Misas A; Galvez Cardenas KM; Ramirez Quintero JD
    Cureus; 2020 Apr; 12(4):e7566. PubMed ID: 32382468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
    Chohan KL; Paludo J; Vallumsetla N; Larson D; King RL; He R; Gonsalves W; Inwards D; Witzig TE; Swaika A; Jain T; Leung N; Ailawadhi S; Reeder CB; Lacy MQ; Rajkumar SV; Kumar S; Kyle RA; Gertz MA; Ansell SM; Kapoor P
    Am J Hematol; 2023 Mar; 98(3):432-439. PubMed ID: 36588384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rory Morrison WMUK Registry for Waldenström macroglobulinaemia: The growth of a national registry for a rare disorder.
    Uppal E; Khwaja J; Bomsztyk J; McCarthy H; Kothari J; Walton P; Scorer H; Kyriakou C; El-Sharkawi D; D'Sa S
    Br J Haematol; 2023 Jun; 201(5):905-912. PubMed ID: 36698318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral Choroidal Infiltrates as the Initial Manifestation of Waldenström Macroglobulinemia Relapse.
    Tan J; Chandra V; Hall AJ
    J Vitreoretin Dis; 2022; 6(2):158-162. PubMed ID: 37008658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Waldenström macroglobulinemia.
    Smith T; Wong M; Goldson TM; Forjuoh SN
    Proc (Bayl Univ Med Cent); 2019 Jul; 32(3):394-396. PubMed ID: 31384197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic.
    Talaulikar D; Advani RH; Branagan AR; Buske C; Dimopoulos MA; D'Sa S; Kersten MJ; Leblond V; Minnema MC; Owen RG; Palomba ML; Tedeschi A; Trotman J; Varettoni M; Vos JM; Treon SP; Kastritis E; Castillo JJ
    Hemasphere; 2020 Aug; 4(4):e433. PubMed ID: 32803133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management.
    Gertz MA
    Am J Hematol; 2023 Feb; 98(2):348-358. PubMed ID: 36588395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.